Document ID: chunk:federal_register_of_legislation:F2025C00158:clause:4_1:p17
Version: federal_register_of_legislation:F2025C00158
Segment Type: clause
Provision Reference: sch 4 cl 1 (pt 17/191)
Character Range: 9633547–9646490

August 2014; AND
                                                                                                                                                                                                                               Patient must not have progressive disease;
                                                                                                                                                                                                                               Patient must have a wild type epidermal growth factor receptor (EGFR) gene.  or
                                                                                                                                                                                                                               Patient must have an epidermal growth factor receptor (EGFR) gene of unknown type.
C4601               P4601          CN4601           Macrogol 3350                                                                                                                                                              Faecal impaction
                                                                                                                                                                                                                               The condition must be inadequately controlled with first line interventions such as bulk-forming agents.
C4649               P4649          CN4649           Eribulin                                                                                                                                                                   Locally advanced or metastatic breast cancer                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             Compliance with Authority Required procedures - Streamlined Authority Code 4649
                                                                                                                                                                                                                               Patient must have progressive disease; AND
                                                                                                                                                                                                                               Patient must have failed at least two prior chemotherapeutic regimens for this condition; AND
                                                                                                                                                                                                                               The treatment must be the sole PBS-subsidised therapy for this condition.
C4651               P4651          CN4651           Triglycerides - medium chain, formula                                                                                                                                      Hyperlipoproteinaemia type 1

C4652               P4652          CN4652           Triglycerides - medium chain, formula                                                                                                                                      Chylous ascites

C4653               P4653          CN4653           Triglycerides - medium chain, formula                                                                                                                                      Chylothorax

C4656               P4656          CN4656           Perampanel                                                                                                                                                                 Intractable partial epileptic seizures                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Compliance with Authority Required procedures - Streamlined Authority Code 4656
                                                                                                                                                                                                                               Initial
                                                                                                                                                                                                                               The treatment must be in combination with two or more anti-epileptic drugs which includes one second-line adjunctive agent; AND
                                                                                                                                                                                                                               The condition must have failed to be controlled satisfactorily by other anti-epileptic drugs, which includes at least one first-line anti-epileptic agent and at least two second-line adjunctive anti-epileptic agents; AND
                                                                                                                                                                                                                               Must be treated by a neurologist.
C4657               P4657          CN4657           Paclitaxel, nanoparticle albumin-bound                                                                                                                                     Stage IV (metastatic) adenocarcinoma of the pancreas                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     Compliance with Authority Required procedures - Streamlined Authority Code 4657
                                                                                                                                                                                                                               The treatment must be in combination with gemcitabine; AND
                                                                                                                                                                                                                               The condition must not have been treated previously with PBS-subsidised therapy; AND
                                                                                                                                                                                                                               Patient must have an Eastern Cooperative Oncology Group (ECOG) performance status score of 2 or less.
                                                                                                                                                                                                                               A patient who has progressive disease when treated with this drug is no longer eligible for PBS-subsidised treatment with this drug.
C4658               P4658          CN4658           Perampanel                                                                                                                                                                 Intractable partial epileptic seizures                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Compliance with Authority Required procedures - Streamlined Authority Code 4658
                                                                                                                                                                                                                               Continuing
                                                                                                                                                                                                                               Patient must have previously been issued with an authority prescription for this drug.
C4659               P4659          CN4659           Triglycerides - medium chain, formula                                                                                                                                      Long chain fatty acid oxidation disorders

C4660               P4660          CN4660           Triglycerides - medium chain, formula                                                                                                                                      Dietary management of conditions requiring a source of medium chain triglycerides
                                                                                                                                                                                                                               Patient must have fat malabsorption due to liver disease.  or
                                                                                                                                                                                                                               Patient must have fat malabsorption due to short gut syndrome.  or
                                                                                                                                                                                                                               Patient must have fat malabsorption due to cystic fibrosis.  or
                                                                                                                                                                                                                               Patient must have fat malabsorption due to gastrointestinal disorders.
C4680               P4680          CN4680           Escitalopram                                                                                                                                                               Major depressive disorders

C4681               P4681          CN4681           Escitalopram                                                                                                                                                               Moderate to severe social anxiety disorder (social phobia, SAD)
                                                                                                                                                                                                                               The condition must be defined by Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-V) criteria; AND
                                                                                                                                                                                                                               Patient must not have responded to non-pharmacological therapy; AND
                                                                                                                                                                                                                               Patient must have been assessed by